HSBC Issues Pessimistic Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price objective lowered by equities researchers at HSBC from $653.00 to $604.00 in a research report issued on Wednesday,MarketScreener reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. HSBC’s price objective suggests a potential upside of 26.14% from the stock’s previous close.

A number of other research firms have also recently commented on ISRG. Truist Financial decreased their price target on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a report on Wednesday, April 15th. JPMorgan Chase & Co. decreased their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a report on Wednesday. Sanford C. Bernstein raised their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Barclays set a $651.00 price target on Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday. Finally, Raymond James Financial decreased their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a report on Wednesday. Eighteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $581.91.

Intuitive Surgical Stock Down 1.0%

Shares of NASDAQ:ISRG opened at $478.82 on Wednesday. The firm’s 50 day moving average price is $477.54 and its 200-day moving average price is $515.16. Intuitive Surgical has a twelve month low of $427.84 and a twelve month high of $603.88. The stock has a market capitalization of $170.04 billion, a PE ratio of 58.04, a price-to-earnings-growth ratio of 3.78 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter in the prior year, the business earned $1.81 EPS. The business’s quarterly revenue was up 23.0% on a year-over-year basis. Analysts expect that Intuitive Surgical will post 8.16 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president owned 1,613 shares in the company, valued at approximately $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in ISRG. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $25,000. Newbridge Financial Services Group Inc. grew its stake in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $28,000. Finally, Caitlin John LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and raised outlook — ISRG reported stronger‑than‑expected Q1 revenue and EPS, raised full‑year procedure guidance and cited broad procedure adoption; that drove the initial rally after the print. Read More.
• Positive Sentiment: da Vinci 5 and innovation-led revenue — Analysts and coverage note revenues are outpacing procedures as da Vinci 5 placements and service/consumable pricing power shift growth toward innovation and value-based revenue. Read More.
• Positive Sentiment: Analysts reaffirm bullish views — several firms reiterated buy/overweight ratings and raised forecasts after the quarter, saying procedure momentum and platform adoption support longer‑term upside. Read More.
• Neutral Sentiment: Market commentary highlights long‑term case — investment pieces argue ISRG remains a secular winner in robotic surgery despite near‑term volatility; these are thematic views rather than short‑term catalysts. Read More.
• Negative Sentiment: Mixed/trimmed price targets — several banks trimmed price targets post‑earnings (some materially) even while keeping buy/overweight ratings; the patchwork of cuts likely contributed to selling pressure. Read More.
• Negative Sentiment: Cybersecurity note — the company disclosed a contained cyber incident and is remediating; while management calls it contained, such disclosures can increase near‑term uncertainty for investors. Read More.
• Negative Sentiment: Guidance conservatism / profit‑taking — some coverage points out the company raised guidance modestly relative to the beat, which may signal conservative assumptions and prompted traders to book gains after the initial surge. Read More.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.